Predict your next investment

Corporation
HEALTHCARE | Disease Diagnosis
epigenomics.com

See what CB Insights has to offer

Founded Year

1998

Stage

PIPE - II | IPO

About Epigenomics

Epigenomics is a molecular diagnostics company focusing on blood-based detection of cancers using its proprietary DNA methylation technology. The company develops and commercializes blood-based diagnostic products across multiple cancer indications with high medical need.

Epigenomics Headquarter Location

Geneststrasse 5

Berlin, 10829,

Germany

+49 30 24345-0

Latest Epigenomics News

People in the News: New Appointments at Rebus Biosystems, Jumpcode Genomics, Epigenomics, More

Nov 19, 2021

Save for later Rebus Biosystems: Viet Truong and Ramesh Ramakrishnan Spatial omics firm Rebus Biosystems has added Viet Truong as VP of operations and Ramesh Ramakrishnan as senior VP of product development. Truong has nearly three decades of experience in the medical device industry. He comes to Rebus from AccuVein, where he was VP of operations. Truong holds an MBA from the University of Phoenix. Ramakrishnan brings more than 25 years of product development experience in the life science industry. He was senior VP of R&D at Talis Biomedical and has held executive positions at Dovetail Genomics and Fluidigm. He holds a doctorate in zoology from Georgetown University. Jumpcode Genomics: Brandon Poe Jumpcode Genomics has appointed Brandon Poe as CFO. He will be responsible for overseeing all aspects of the company's finance, operations, and strategic initiatives. Poe brings 25 years of financial experience in the life sciences, medical devices, and genomics services industries. He most recently served as CFO of genomic telehealth provider Genome Medical. Prior to that, he was VP of finance at Illumina and held senior finance positions at other companies including Sotera Wireless and Inverness Medical Innovations. Epigenomics: Andrew Lukowiak The supervisory board of Epigenomics has appointed Andrew Lukowiak as president and CSO, effective Dec. 1. Lukowiak will become a member of Epigenomics' executive board and will oversee research and development, as well as operations. Lukowiak previously served as CEO and board member for Millennium Health, chief operating officer at AltheaDx, and a senior research and development executive at GenMark Diagnostics and Hologic. For additional recent items on appointments, promotions, and awards in omics and molecular diagnostics, please see the People in the News page on our website.

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Epigenomics

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Epigenomics is included in 3 Expert Collections, including Cancer.

C

Cancer

3,710 items

Products/services that analyze tumor-derived biomarkers (ctDNA, CTCs, exosomes) in blood/urine/other non-invasive liquid specimens to detect cancer earlier, guide treatment, and monitor progress. *Data fields manually updated as new information becomes available.'

O

Omics

1,029 items

Companies involved in the capture, sequencing, and/or analysis of genomic, transcriptomic, proteomic, and/or metabolomic data

M

Medical Devices

295 items

Companies that received PMA from the FDA since 2014. Companies tagged as #FDAPMA

Epigenomics Patents

Epigenomics has filed 67 patents.

The 3 most popular patent topics include:

  • Molecular biology
  • Genetics
  • DNA
patents chart

Application Date

Grant Date

Title

Related Topics

Status

4/17/2006

8/4/2020

Molecular biology, DNA, Genetics, Medical tests, Blood tests

Grant

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

00/00/0000

00/00/0000

Subscribe to see more

Subscribe to see more

Subscribe to see more

Application Date

4/17/2006

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Grant Date

8/4/2020

00/00/0000

00/00/0000

00/00/0000

00/00/0000

Title

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Related Topics

Molecular biology, DNA, Genetics, Medical tests, Blood tests

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Status

Grant

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Epigenomics Web Traffic

Rank
Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Epigenomics Rank

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.